Company intelligence / Profile preview

ANT Neuro

Hengelo, Overijssel, Netherlandsant-neuro.com ↗

Ownership: Private
Development stage: Commercial

Overview

ANT Neuro’s products are commercially available worldwide for clinical diagnostics and neuroscience research. Their FDA-cleared visor2™ supports navigated TMS therapy. The eego™ HD EEG system provides high-density brain activity recording for both human and animal applications. No drug or therapeutic clinical trial results apply as the company focuses on devices.

Therapeutic areas: OtherPsychiatryNeurology
Modalities: DeviceNon-pharmacological therapy (e.g., neurofeedback)Neuromodulation device (e.g., TMS systems)Diagnostic device (EEG/EMG/MEG/MRI integration)
Industry: Physiological Monitoring

Partnerships

MAG & More GmbH for rTMS stimulatorsmammal.tech for mobile animal EEG solutions

Beyond the preview

Go deeper on ANT Neuro.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ANT Neuro.

Explore the full profile